1. Home
  2. MNDY vs STVN Comparison

MNDY vs STVN Comparison

Compare MNDY & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo monday.com Ltd.

MNDY

monday.com Ltd.

N/A

Current Price

$76.05

Market Cap

7.4B

Sector

Technology

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$15.22

Market Cap

4.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
MNDY
STVN
Founded
2012
1949
Country
Israel
Italy
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
4.2B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MNDY
STVN
Price
$76.05
$15.22
Analyst Decision
Buy
Buy
Analyst Count
25
4
Target Price
$174.92
$25.13
AVG Volume (30 Days)
3.0M
594.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.42%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.70
$10.26
Revenue Next Year
$16.48
$10.02
P/E Ratio
$34.38
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$68.68
$13.91
52 Week High
$316.98
$28.00

Technical Indicators

Market Signals
Indicator
MNDY
STVN
Relative Strength Index (RSI) 36.83 43.75
Support Level $68.80 $14.03
Resistance Level $79.30 $17.14
Average True Range (ATR) 4.09 0.88
MACD 2.68 0.09
Stochastic Oscillator 53.26 30.33

Price Performance

Historical Comparison
MNDY
STVN

About MNDY monday.com Ltd.

Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: